Novelion therapeutics inc. (NVLN)
CashFlow / Yearly
Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Cash used in operating activities
Net Income (Loss) Attributable to Parent

-108,300

-126,710

-52,870

-23,009

-4,071

-

-

-

-17,539

99,434

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation

1,700

2,000

264

576

891

-

-

-

-

1,403

Amortization of intangible assets

25,100

25,052

2,134

0

0

-

-

-

-

-

Write-down of fixed assets, investments and deposit

-

-

-

-

-

-

-

-

-

448

Stock-based compensation

3,060

4,537

797

2,330

1,453

599

5,751

2,973

2,494

2,161

Non-cash interest expense

39,670

32,954

2,676

0

0

-

-

-

-

-

Net loss and comprehensive loss

-

-

-

-

-

-24,871

-

-

-

-

Net loss and comprehensive loss

-

-

-

-

-

-

45,698

-30,416

-

-

Depreciation

-

-

-

-

-

964

1,254

1,433

-

-

Depreciation

-

-

-

-

-

-

-

-

1,202

-

Provision for inventory excess and obsolescence

2,100

18,800

0

0

-

-

-

-

-

8,114

Unrealized foreign exchange loss (gain)

-2,925

832

-

-

-

-

-

-

-

-

Amortization of debt issuance costs and debt discount

3,132

0

-

-

-

-

-

-

-

-

Fair value change in contingent consideration

-

-

-2,042

0

-2,000

-

-

-

-

-

Unrealized foreign exchange (gain) loss

-

-

118

-120

-

-

-

-

-

-

Unrealized foreign exchange loss

-

-

-

-

-75

-254

-166

-131

331

-2,290

Fair value loss on investment

-

-

-10,704

0

0

-

-

-

-

-

Recovery on assets held for sale

-

-

-

-

-

153

0

-

-

-

Gain on sale of discontinued operations (Note 12)

-

-

-

-

-

1,053

101,412

-

-

-

Deferred income taxes

-

-

-

-

-

-

-

-

-

-5,510

Loss on sale of long-lived assets

-

-

-

-

-

221

45

269

425

-

Fair value loss on investment

-

-

-

-

0

-

-

-

-

-

Deferred income taxes

857

138

-214

18

-177

-

-

-

-

-

Other non-cash operating activities

-3

83

50

-25

-

-

-

-

-

-

Gain (Loss) on Extinguishment of Debt

-4,300

0

-

-

-

-

-

-

-

-

Deferred income taxes

-

-

-

-

-

-730

-1,779

-3,661

-12,872

-

Impairment of long-lived assets

-

-

-

-

0

64

1,056

-

-

-

Fair value change in contingent consideration (Notes 7, 14)

-

-

-

-

-

-1,273

0

-

-

-

Changes in assets and liabilities:
Accounts receivable

6,745

12,852

893

-10

-73

-2,306

-6,777

-1,029

1,186

-8,143

Inventories

1,700

-6,081

-2,079

0

0

-

-361

-2,118

-1,006

833

Interest on restricted cash

-

-

-

-

-

-

-

-

-

295

Secured note receivable - current

-

-

-

-

-

-

-

-

741

250

Prepaid expenses and other assets

4,380

-19,541

-705

-442

-810

421

-888

-2,139

-

-

Gain on sale of discontinued operations

-

-

-

-

-

-

-

-

-

107,363

Appeal bond collateral

-

-

-

-

-

-

-

-

-

-124,622

Long-term deposits and other assets

-

-

-

-

-

-

-

-

-3,115

-5,599

Accounts payable

-10,720

-3,932

4,441

-184

-607

-2,916

310

236

2,040

-1,920

Accrued liabilities and other liabilities

-6,449

-19,823

-6,389

603

108

-

-

-

-

-

Accrued restructuring

-

-

-

-

-130

-1,803

1,954

-

-

-743

Income taxes receivable/payable

-

-

-

-

30

-

-

-

-

-

Deferred income

-

-

-

-

-

-

-

-

-4,244

-1,723

Other accrued liabilities

-

-

-

-

-

-

-

-

-

-124,306

Net Cash Provided by (Used in) Operating Activities

-55,500

-54,899

-34,356

-19,359

455

-25,817

-41,580

-16,578

4,449

56,642

Cash used in investing activities
Net proceeds from sale of discontinued operations (Note 12)

-

-

-

-

-

8,486

101,461

-

-

-

Net proceeds from sale of investment in QLT USA

-

-

-

-

-

-

-

-

10,000

16,477

Purchases of property and equipment

442

754

155

9

25

223

892

3,317

1,589

1,094

Cash acquired in Merger

-

-

28,290

0

0

-

-

-

-

-

Loan receivable

-

-

3,000

0

-

-

-

-

-

-

Cash consideration for acquisition - loan to Aegerion (Note 5)

-

-

-

-

0

-

-

-

-

-

Income taxes receivable

-

-

-

-

-

478

-265

-937

5,553

47,371

Accrued liabilities

-

-

-

-

-

-1,047

-5,852

1,324

633

-

Net proceeds from sale of long-lived assets

-

-

192

43

115

102

767

19

108

116

Net proceeds from sale of other assets

-

-

-

-

-

-

-

-

317

-

Proceeds from mortgage receivable

-

-

-

-

-

-

5,874

2,004

3,822

-

Proceeds from contingent consideration (Notes 16)

-

-

-

-

36,582

34,599

28,845

30,641

20,490

5,162

Other

-

-

-

-

-

-66

0

-

-

-

Net cash used in investing activities

-442

-754

25,327

34

36,672

43,030

136,055

29,347

33,148

20,661

Cash provided by financing activities
Net proceeds from loan facilities

70,000

0

-

-

-

-

-

-

-

-

Issuance of common shares

354

109

21,481

5,508

509

8,317

20,417

2,182

910

125

Repayment of Shareholder Term Loans

20,000

0

-

-

-

-

-

-

-

-

Payment of Shareholder Term Loan issuance costs

2,966

0

-

-

-

-

-

-

-

-

Common shares repurchased, including fees

-

-

-

-

-

14,079

13,096

18,839

17,246

55,911

Cash distribution to common shareholders

-

-

15,000

0

0

200,000

0

-

-

-

Settlement of Backstop Agreement

-

-

15,000

0

0

-

-

-

-

-

Aralez investment

-

-

45,000

0

0

-

-

-

-

-

Net cash (used in) provided by financing activities

47,388

109

-23,519

5,508

509

-205,762

-

-16,657

-16,336

-55,786

Net cash provided by (used in) financing activities

-

-

-

-

-

-

7,321

-

-

-

Exchange rate effect on cash

-1,756

2,047

-349

-267

-249

-314

-9

7

103

1,202

Net decrease in cash and cash equivalents

-10,276

-53,497

-32,897

-14,084

37,387

-188,863

101,787

-3,881

21,364

22,719

Supplemental disclosures of cash flow information
Cash paid for interest

8,182

6,500

33

0

0

-

-

-

-

-

Interest paid

-

-

-

-

-

-

-

-

0

1,832

Cash paid for taxes, net

42

1,671

105

0

0

0

392

994

2,002

6,305

Non-cash investing activities
Shares issued in the acquisition (Note 5)

-

-

-

-

0

-

-

-

-

-

Convertible notes of Aegerion, at fair value (Note 10)

-

-

-

-

0

-

-

-

-

-

Non-cash investing activities and financing activities:
Purchases of property and equipment included in accounts payable

10

122

61

0

0

-

-

-

-

-

Non-cash financing activities
Refinance from Roll Up Loans

22,500

0

-

-

-

-

-

-

-

-

Retirement of Convertible Notes

22,500

0

-

-

-

-

-

-

-

-